Meeting Coverage:

Association for Research in Vision & Ophthalmology

ARVO: 2023

The Risk of iRORA Revealed

Show Description +

Hanna Choi, BS, explains her research that suggests 1/3 of patients with fellow-eye wet AMD will develop iRORA in the eye with intermediate AMD.

Posted: 5/15/2023

Up Next

Tackling the Diabetic Retinopathy "Pandemic"

Tien Yin Wong, MBBS, MMED (Ophth), MPH, PhD


DAVIO Trial Updates

Ashkan M. Abbey, MD

The Latest From LIGHTSITE III

Marion R. Munk, MD, PhD

New Phase 1 Data for OTX-TKI

Andrew Moshfeghi, MD

The Value of Multimodal Imaging in Diabetic Retinopathy

Stela Vujosevic, MD, PhD, FARVO, FEBO

The Risk of iRORA Revealed

Hanna Choi, BS, explains her research that suggests 1/3 of patients with fellow-eye wet AMD will develop iRORA in the eye with intermediate AMD.

Posted: 5/15/2023


Please log in to leave a comment.

More From ARVO: 2023 Coverage